A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

计划入组 38 人 · 首次发布于 2026 年 1 月 23 日

T1 Mapping in Fabry Disease

计划入组 70 人 · 首次发布于 2023 年 6 月 28 日

Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)

计划入组 54 人 · 首次发布于 2017 年 6 月 2 日

T1-116C

T1-1081

[18F]T1

CARRICK THERAPEUTICS LIMITED

Ireland

Caprice Resources Ltd

EPA Approves CRISPR-Based HLB-Resistant Citrus Rootstock to Combat Citrus Greening

Trimodal Therapy Shows Promise for Recurrent High-Grade T1 Bladder Cancer

Tempus AI Receives FDA 510(k) Clearance for Enhanced Cardiac Imaging Platform with T1 and T2 Mapping Capabilities